Purpose-built for physicians Off-label semaglutide, tirzepatide lower HbA1c, weight in type 1 diabetes Key takeaways: Adults with type 1 diabetes had greater declines in HbA1c and body weight 1 year after being prescribed semaglutide or tirzepatide
Macronutrient blends expanded at a 14.1% CAGR through 2030
Requires medical supervision dose escalation and side-effect monitoring are essential
Li, Z., Chen, X., Vong, J
These medications, belonging to the GLP-1 receptor agonist class, have revolutionized the treatment of type 2 diabetes and obesity
When administered, Ozempic binds to GLP-1 receptors in multiple areas of the body, including the pancreas, gastrointestinal tract, and importantly, the hypothalamusthe brain region responsible for regulating hunger and satiety